共 127 条
[1]
Khan SA(2002)Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 806-813
[2]
Taylor-Robinson SD(2019)Classifications and misclassification in cholangiocarcinoma Liver Int 39 260-262
[3]
Toledano MB(2013)Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections Ann Surg 258 129-140
[4]
Beck A(2010)Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality J Hepatobiliary Pancreat Sci 17 455-462
[5]
Elliott P(1992)Management strategies in resection for hilar cholangiocarcinoma Ann Surg 215 31-38
[6]
Thomas HC(2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews J Clin Epidemiol 134 178-189
[7]
Cardinale V(2017)AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BMJ 358 790-799
[8]
Nagino M(2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Rev Esp Cardiol (Engl Ed) 74 16-1805
[9]
Ebata T(2007)Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 135-444
[10]
Yokoyama Y(2014)Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range BMC Med Res Methodol 14 1785-22